274 related articles for article (PubMed ID: 16707786)
1. Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.
Wilcock DM; Alamed J; Gottschall PE; Grimm J; Rosenthal A; Pons J; Ronan V; Symmonds K; Gordon MN; Morgan D
J Neurosci; 2006 May; 26(20):5340-6. PubMed ID: 16707786
[TBL] [Abstract][Full Text] [Related]
2. Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice.
Kukar T; Prescott S; Eriksen JL; Holloway V; Murphy MP; Koo EH; Golde TE; Nicolle MM
BMC Neurosci; 2007 Jul; 8():54. PubMed ID: 17650315
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid.
Wilcock DM; Jantzen PT; Li Q; Morgan D; Gordon MN
Neuroscience; 2007 Feb; 144(3):950-60. PubMed ID: 17137722
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice.
Petrushina I; Ghochikyan A; Mktrichyan M; Mamikonyan G; Movsesyan N; Davtyan H; Patel A; Head E; Cribbs DH; Agadjanyan MG
J Neurosci; 2007 Nov; 27(46):12721-31. PubMed ID: 18003852
[TBL] [Abstract][Full Text] [Related]
6. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
[TBL] [Abstract][Full Text] [Related]
7. Deglycosylated anti-Abeta antibody dose-response effects on pathology and memory in APP transgenic mice.
Karlnoski RA; Rosenthal A; Alamed J; Ronan V; Gordon MN; Gottschall PE; Grimm J; Pons J; Morgan D
J Neuroimmune Pharmacol; 2008 Sep; 3(3):187-97. PubMed ID: 18607758
[TBL] [Abstract][Full Text] [Related]
8. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
[TBL] [Abstract][Full Text] [Related]
9. Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration.
Takata K; Hirata-Fukae C; Becker AG; Chishiro S; Gray AJ; Nishitomi K; Franz AH; Sakaguchi G; Kato A; Mattson MP; Laferla FM; Aisen PS; Kitamura Y; Matsuoka Y
Eur J Neurosci; 2007 Nov; 26(9):2458-68. PubMed ID: 17970733
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain.
Bürger S; Noack M; Kirazov LP; Kirazov EP; Naydenov CL; Kouznetsova E; Yafai Y; Schliebs R
Int J Dev Neurosci; 2009 Oct; 27(6):517-23. PubMed ID: 19589380
[TBL] [Abstract][Full Text] [Related]
11. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
Meilandt WJ; Cisse M; Ho K; Wu T; Esposito LA; Scearce-Levie K; Cheng IH; Yu GQ; Mucke L
J Neurosci; 2009 Feb; 29(7):1977-86. PubMed ID: 19228952
[TBL] [Abstract][Full Text] [Related]
12. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
13. Improvement of memory deficits and amyloid-β clearance in aged APP23 mice treated with a combination of anti-amyloid-β antibody and LXR agonist.
Fitz NF; Castranio EL; Carter AY; Kodali R; Lefterov I; Koldamova R
J Alzheimers Dis; 2014; 41(2):535-49. PubMed ID: 24643138
[TBL] [Abstract][Full Text] [Related]
14. Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of Aβ amyloidosis.
Liao F; Hori Y; Hudry E; Bauer AQ; Jiang H; Mahan TE; Lefton KB; Zhang TJ; Dearborn JT; Kim J; Culver JP; Betensky R; Wozniak DF; Hyman BT; Holtzman DM
J Neurosci; 2014 May; 34(21):7281-92. PubMed ID: 24849360
[TBL] [Abstract][Full Text] [Related]
15. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
[TBL] [Abstract][Full Text] [Related]
16. Improving memory and decreasing cognitive impairment in Tg-APPswe/PSEN1dE9 mice with Aβ3-10 repeat fragment plasmid by reducing Aβ deposition and inflammatory response.
Ma Y; Li Y; Zong LX; Xing XN; Zhang WG; Cao YP
Brain Res; 2011 Jul; 1400():112-24. PubMed ID: 21658683
[TBL] [Abstract][Full Text] [Related]
17. Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice.
Petrushina I; Ghochikyan A; Mkrtichyan M; Mamikonyan G; Movsesyan N; Ajdari R; Vasilevko V; Karapetyan A; Lees A; Agadjanyan MG; Cribbs DH
J Neuroinflammation; 2008 Sep; 5():42. PubMed ID: 18823564
[TBL] [Abstract][Full Text] [Related]
18. Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice.
Gordon MN; King DL; Diamond DM; Jantzen PT; Boyett KV; Hope CE; Hatcher JM; DiCarlo G; Gottschall WP; Morgan D; Arendash GW
Neurobiol Aging; 2001; 22(3):377-85. PubMed ID: 11378242
[TBL] [Abstract][Full Text] [Related]
19. Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer's disease mouse model.
Chen B; Bromley-Brits K; He G; Cai F; Zhang X; Song W
Curr Alzheimer Res; 2010 May; 7(3):255-61. PubMed ID: 20043809
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy reduces vascular amyloid-beta in PDAPP mice.
Schroeter S; Khan K; Barbour R; Doan M; Chen M; Guido T; Gill D; Basi G; Schenk D; Seubert P; Games D
J Neurosci; 2008 Jul; 28(27):6787-93. PubMed ID: 18596154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
